|
PRELIMINARY PROGRAM
| Tuesday, October 28, 2008 |
| 3:00pm-5:00pm |
Registration, Check-In |
| Wednesday, October 29, 2008 |
| |
8:00am-6:00pm |
Registration, Check-In
|
| |
9:00am-5:30pm |
Special Symposium - Clonality Assessment in
Hematopathology: European and
North American Perspectives
Moderators: Iris Schrijver, MD and James L. Zehnder, MD,
Stanford University School of Medicine, Stanford, CA, USA
(Please select on registration form
if you wish to attend this event)
>>See
complete program description |
| |
5:30pm-10:00pm |
AMP Council Meeting I
|
|
Thursday, October 30, 2008
|
| |
7:00am-5:00pm |
Registration, Check-In
|
| |
9:00am-5:00pm |
Corporate Workshops (See separate
Corporate Workshop
schedule) |
| |
7:30am-3:30pm |
PATHOLOGY OUTREACH COURSE
Molecular Diagnostics Applications in
Pathology: A Case-Oriented Approach,
A course for Non-Molecular Laboratory Professionals
Premier Suporter: Nanosphere, Inc.
>>See complete program description - separate registration
required |
| |
4:00pm-5:00pm |
CPT
Committee Meeting |
| |
5:00pm-6:00pm |
AMP Committee Meetings |
| |
|
|
Clinical Practice Committee |
| |
|
|
Membership and Professional
Development |
| |
|
|
Nominating Committee |
| |
|
|
Program Committee |
| |
|
|
Publications Committee |
| |
|
|
Training & Education Committee |
| |
5:00pm-7:00pm |
Professional Relations Committee |
| |
6:00pm-7:00pm |
MGP Fellowship Program
Directors Meeting |
| |
6:00pm-8:00pm |
Strategic Planning Committee
Meeting |
| |
6:00pm-9:00pm |
Abbott Molecular Evening
Reception |
| |
7:00pm-11:00pm |
Dinner for Canadian Members |
|
Friday, October 31, 2008 |
| |
7:00am-6:00pm |
Registration, Check-In
|
| |
7:00am-8:00am |
Early Bird Sessions |
| |
|
|
How to Assess Significance of Nucleotide Sequence Variants |
| |
|
|
Hanna Rennert, PhD, Weill Cornell Medical College, New
York, NY |
| |
|
|
Array-Based Genotyping in Lymphoma and Leukemia |
| |
|
|
Moderator: Kojo Elenitoba-Johnson, MD, University of
Michigan Medical School, Ann Arbor, MI |
| |
|
|
Harvey Greisman, MD, PhD, University of Washington, Seattle, WA |
| |
|
|
Jaroslaw P. Maciejewski, MD, PhD, Cleveland Clinic, Cleveland,
OH |
| |
|
|
Microorganism Identification by
Sequence Analysis |
| |
|
|
Cathy Petti, MD, ARUP Laboratories, Salt Lake City, UT |
| |
|
|
Nancy Wengenack, PhD, Mayo Clinic, Rochester, MN |
| |
8:00am-8:15am |
Break |
| |
8:15am-8:20am |
Opening Remarks
Jeffrey A. Kant, MD, PhD, University of Pittsburgh School of Medicine,
Pittsburgh, PA |
| |
8:20am-9:30am |
AMP AWARD FOR EXCELLENCE IN MOLECULAR
DIAGNOSTICS LECTURE
Carl Wittwer, MD, PhD, ARUP Laboratories, Salt Lake City, UT
Supported by Roche Diagnostics Corporation |
| |
9:30am-10:30am |
Break - Visit Exhibits and
Posters Supported
by BioTrove |
| |
10:30am-12:00noon |
PLENARY SESSION I: HEMATOPATHOLOGY |
| |
|
Interactions Between Epigenomics and Mutations in Leukemia |
| |
|
Moderator: Dan Jones, MD, PhD, UT-MD Anderson Cancer Center, Houston, TX |
| |
|
Jay Hess, MD, PhD, University of Michigan Medical School, Ann Arbor, MI |
| |
|
Guido Marcucci, MD, Ohio State University, Columbus, OH |
| |
12:00noon-1:00pm |
General Luncheon |
| |
12:00noon-1:00pm |
Genetics Business Luncheon |
| |
12:00noon-1:00pm |
Infectious Diseases Business
Luncheon |
| |
12:00noon-1:00pm |
Trainee Luncheon |
| |
1:00pm-2:30pm |
CONCURRENT WORKSHOPS |
| |
|
|
Puzzlers by Prior
Thomas W. Prior, PhD, Ohio State University, Columbus, OH |
| |
|
|
Stem Cell Transplant Monitoring and Engraftment |
| |
|
|
Moderator: Dan Jones, MD, PhD, University of Texas MD
Anderson Cancer Center, Houston, TX |
| |
|
|
Michael P. Busch, MD, PhD, Blood Systems Research Institute, San
Francisco, CA |
| |
|
|
Elizabeth J. Shpall, MD, University of Texas MD Anderson Cancer
Center, Houston, TX |
| |
|
|
Current Update on Hepatitis B virus
Teresa L. Wright, MD, Roche Molecular Systems,
Pleasanton, CA |
| |
|
|
Promise and Challenges in Personalized Medicine |
| |
|
|
Moderator: Timothy J. O'Leary, MD, PhD, Department of
Veterans Affairs, Washington, DC |
| |
|
|
Kathy Hudson, PhD, The Genetics and Public Policy Center,
Washington, DC |
| |
|
|
Debra G.B. Leonard, MD, PhD, Weill Cornell Medical College, New
York, NY |
| |
2:30pm-4:30pm |
Break-Visit
Exhibits &
Posters
Supported by NorDiag
2:30-3:30, Even-numbered posters manned |
| |
|
All YIA and Tech Award posters manned |
| |
4:30pm-6:00pm |
PLENARY SESSION II: SOLID
TUMORS |
| |
|
Emerging Biomarkers: MicroRNAs & Epigenomics |
| |
|
Moderator: William P. Bennett, MD, City of Hope
National Medical Center, Duarte, CA |
| |
|
MicroRNAs in Tumorigenesis: a Primer |
| |
|
Wayne Tam, MD, PhD, Weill Medical College of Cornell University, New
York, NY |
| |
|
Epigenomic Changes in Cancer |
| |
|
Peter A. Jones, PhD, University of Southern California,
Los Angeles, CA |
| |
6:00pm-7:00pm |
Welcome Reception
Supported by Roche Diagnostics Corporation |
| |
7:00pm-8:30pm |
JMD Editorial
Board Meeting |
Saturday, November 1, 2008
|
| |
7:00am-6:00pm |
Registration, Check-In
|
| |
7:00am-8:00am |
Early Bird Sessions |
| |
|
|
CPT Coding Conundrums |
| |
|
|
Jeffrey A. Kant, MD, PhD, University of Pittsburgh School of
Medicine, Pittsburgh, PA |
| |
|
|
Jan A. Nowak, MD, PhD, Advocate Lutheran General Hospital,
Rosemont, IL |
| |
|
 |
Applications of Tissue Identity Testing |
| |
|
|
Winand Dinjens, PhD, Erasmus MC/Josephine Nefkens Institute,
Rotterdam, THE NETHERLANDS |
| |
8:00am-8:15am |
Break |
| |
8:15am-9:30am |
PLENARY SESSION III: INFECTIOUS
DISEASES
Supported by an unrestricted educational grant from
Abbott Molecular |
| |
|
Multiplex Assays of Respiratory Targets |
| |
|
Moderator: Franklin Cockerill III, MD, Mayo Clinic, Rochester, MN |
| |
|
Gregory A. Storch, MD, Washington University School of Medicine, St.
Louis, MO |
| |
9:30am-10:00am |
Break - Supported By
Third Wave Technologies |
| |
10:00am-11:30am |
CONCURRENT WORKSHOPS |
| |
|
Platform Presentations of Selected Abstracts
-
Genetics
Moderators: Mary C. Lowery Nordberg, PhD, LSU Health
Sciences Center, Shreveport, LA |
| |
|
|
|
Hanna Rennert, PhD, Weill
Cornell Medical College, New York, NY |
| |
|
Platform Presentations of Selected Abstracts -
Hematopathology
Moderators: Dan Jones, MD, PhD, University of Texas MD
Anderson Cancer Center, Houston,
TX |
| |
|
|
|
Kojo Elenitoba,-Johnson, MD,
University of Michigan Medical School, Ann Arbor, MI |
| |
|
Platform Presentations of Selected Abstracts -
Infectious Diseases
Moderators: Franklin Cockerill III, MD, May Clinic,
Rochester, MN |
| |
|
|
|
Frederick S. Nolte, PhD,
Medical University of South Carolina, Charleston, SC |
| |
|
Platform Presentations of Selected Abstracts -
Solid Tumors
Moderators: Wiliam P. Bennett, MD, City of Hope National
Medical Center, Duarte, CA |
| |
|
|
|
Antonia R. Sepulveda, MD, PhD,
University of Pennsylvania School of Medicine, Philadelphia, PA |
| |
11:30am-12:30pm |
Visit Exhibits
& Posters
Odd-numbered posters manned |
| |
12:30pm-1:30pm |
General Luncheon |
| |
12:30pm-1:30pm |
Hematopathology Business Luncheon |
| |
12:30pm-1:30pm |
Solid Tumors Business Luncheon |
| |
1:30pm-2:45pm |
PLENARY SESSION IV: GENETICS |
| |
|
Genomic Architecture and Copy Number Variation |
| |
|
Moderator: Mary C. Lowery Nordberg, PhD, LSU Health Sciences Center,
Shreveport, LA |
| |
|
James R. Lupski, MD PhD, Baylor College of Medicine, Houston, TX |
| |
2:45pm-4:00pm |
Business/Awards Session |
| |
|
Young Investigator Award
Supported by an unrestricted educational grant from
Luminex Corporation
|
| |
|
Leadership Award
Supported by an unrestricted educational grant from
Abbott Molecular |
| |
|
Technologist Award
Supported by an unrestricted educational grant from
Third Wave Technologies |
| |
4:00pm-5:00pm |
Awards Reception
Supported by Third Wave Technologies |
| |
5:00pm-6:30pm |
CONCURRENT WORKSHOPS |
| |
|
 |
Array CGH/Copy Number Variants |
| |
|
|
Bassem A. Bejjani, MD, FACMG, Signature Genomic
Laboratories, Spokane, WA |
| |
|
|
Gail E. Herman, MD, PhD, The Research Institute at Nationwide
Children's Hospital, Columbus, OH |
| |
|
|
Livija Medne, MD, Children's Hospital of Philadelphia,
Philadelphia, PA |
| |
|
|
Quantitative Testing for BK Polyomavirus |
| |
|
|
Moderator: Aaron D. Bossler, MD, PhD, University of Iowa College of
Medicine, Iowa City, IA |
| |
|
|
Clinical Applications
Frederick S. Nolte, PhD,
Medical University of South Carolina, Charleston, SC |
| |
|
|
Assay Design, Validation,
and Reference Materials
Linda Cook, PhD, University of Washington, Seattle, WA |
| |
|
|
Technical Topics Puzzlers |
| |
|
|
Moderator: Karen Bijwaard, MS,
CLSp(MB), Food and Drug Administration, Rockville, MD |
| |
|
|
Christine C. Ginnochio, PhD, Northshore-LIJ Health System
Labs, Lake Success, NY |
| |
|
|
Rick Press, MD, PhD, Oregon Health Sciences University,
Portland, OR |
| |
|
|
Molecular Testing in Lung Cancer |
| |
|
|
Moderator: William P. Bennett, MD, City of Hope National
Medical Center, Duarte, CA |
| |
|
|
Deregulation of EGFR
Signaling in Lung Cancers and its Clinical Significance
Adi F. Gazdar, MD, University of Texas Southwestern Medical
Center, Dallas, TX |
| |
|
|
Gene Expression Prognostic
Classifier for Early Stage Non-Small Cell Lung Cancer
Ming Sound Tsao, MD, FRCPC, The University Health Network,
Toronto, CANADA |
| |
|
|
Quantitative Gene Expression Analysis of Formalin-Fixed,
Paraffin-Embedded Tissues:
Technical Challenges and Quality Control
Steven Shak, MD, Genomic Health, Redwood City, CA
|
| |
7:00pm-10:00pm |
Saturday Evening Social Event (ticket
purchase required - see meeting registration form)
Supported by Luminex Corporation |
|
Sunday, November 2, 2008 |
| |
7:00am-12:00pm |
Registration, Check-In
|
| |
7:00am-8:00am |
Early Bird Sessions |
| |
|
|
EGFR Evaluation in Lung Cancer |
| |
|
|
Moderator: Mary C. Lowery Nordberg, PhD, LSU Health
Sciences Center, Shreveport, LA |
| |
|
|
Neal Lindeman, MD, Brigham & Women's Hospital, Boston, MA |
| |
|
 |
Bayesian Analysis Workshop
Shuji Ogino, MD, PhD, Brigham & Women's Hospital, Boston,
MA |
| |
|
 |
Personal Genomics
Moderator: Jeffrey A. Kant, MD, PhD, University of Pittsburgh School of
Medicine, Pittsburgh, PA |
| |
|
|
Joanna Mountain, PhD, 23andMe,
Mountain View, CA
|
| |
|
|
Dietrich Stephan, PhD,
Navigenics, Redwood Shores, CA |
| |
8:00am-8:15am |
Break |
| |
8:15am-9:45am |
CONCURRENT WORKSHOPS |
| |
|
|
ABL1 Kinase Mutation Analysis |
| |
|
|
Moderators: |
Dan Jones, MD,
PhD, University of Texas MD Anderson Cancer Center, Houston, TX |
| |
|
|
|
Suzanne Kamel-Reid, PhD, FACMG,
The University Health Network, Toronto, CANADA |
| |
|
|
Kojo Elenitoba-Johnson, MD,
University of Michigan Medical School, Ann Arbor, MI |
| |
|
|
Rick Press, MD, PhD, Oregon
Health Sciences University, Portland, OR |
| |
|
|
David Viswanatha, MD, Mayo
Clinic, Rochester, MN |
| |
|
|
Karen Weck, MD, University of
North Carolina, Chapel Hill, NC |
| |
|
 |
Current Molecular Testing
Approaches for Thyroid, Brain and Gastrointestinal Stromal
Tumors |
| |
|
|
Molecular Pathology of
Gliomas
A. John Iafrate, MD, PhD, Massachusetts General Hospital,
Boston, MA |
| |
|
|
Molecular Pathology of Gastrointestinal and Related Tumors
Markku Miettinen,
MD, Armed Forces Institute of Pathology, Washington, DC |
| |
|
|
Current Molecular Testing Approaches for Thyroid Tumors
Yuri E. Nikiforov, MD, PhD, University of Pittsburgh,
Pittsburgh, PA |
| |
|
|
Clinical, Statistical, and Regulatory Issues for Prognostic
Assays (IVDMIA) |
| |
|
|
Steven Gutman, MD, Food and Drug Administration, Rockville,
MD |
| |
|
|
Estelle Russek-Cohen, PhD, Food and Drug Administration,
Rockville, MD |
| |
|
|
Laura J. Van't Veer, PhD,
Agendia BV, Amsterdam, THE NETHERLANDS |
| |
|
|
New Techniques - Next Generation Sequencing |
| |
|
|
Moderator: Joan Gordon, BS, MT
(ASCP) Maine Molecular Quality Controls, Inc, Scarborough, ME |
| |
|
|
Rong Mao, MD, ARUP Laboratories, Salt Lake City, UT |
| |
|
|
Karl V. Voelkerding, MD, ARUP Laboratories, Salt Lake City, UT |
| |
9:45am-10:00am |
Break |
| |
10:00am-11:45am |
PLENARY SESSION V: SPECIAL
TOPICS |
| |
|
Issues in Clinical Development, Validation and Application of Multiplex
Assays |
| |
|
Moderator: Jeffrey A. Kant, MD, PhD, University of Pittsburgh School of
Medicine,Pittsburgh, PA |
| |
|
Jean Amos Wilson, PhD, Sequenom, Inc, San Diego, CA
|
| |
|
Estelle Russek-Cohen, PhD, Food and Drug Administration, Rockville, MD |
| |
|
Gregory Storch, MD, Washington University School of Medicine, St. Louis,
MO |
| |
|
Steven Gutman, MD, Food and Drug Administration, Rockville, MD
|
| |
11:45am |
Closing Remarks
Jeffrey A. Kant, MD, PhD, University of Pittsburgh School of Medicine,
Pittsburgh, PA |
| |
12:00noon |
Adjourn |
| |
12:30pm-3:00pm |
AMP Council Meeting II |
|
|